Innate Immune Receptors, Key Actors in Cardiovascular Diseases
|Author/s||Jaén, Rafael I.
Smani Hajami, Tarik
López-Sendón, José Luis
|Department||Universidad de Sevilla. Departamento de Fisiología Médica y Biofísica|
|Abstract||Cardiovascular diseases (CVDs) are the leading cause of death in the industrialized world. Most CVDs are
associated with increased inflammation that arises mainly from innate immune system activation related to
Cardiovascular diseases (CVDs) are the leading cause of death in the industrialized world. Most CVDs are associated with increased inflammation that arises mainly from innate immune system activation related to cardiac damage. Sustained activation of the innate immune system frequently results in maladaptive inflam- matory responses that promote cardiovascular dysfunction and remodeling. Much research has focused on determining whether some mediators of the innate immune system are potential targets for CVD therapy. The innate immune system has specific receptors—termed pattern recognition receptors (PRRs)—that not only recognize pathogen-associated molecular patterns, but also sense danger-associated molecular signals. Acti- vation of PRRs triggers the inflammatory response in different physiological systems, including the cardio- vascular system. The classic PRRs, toll-like receptors (TLRs), and the more recently discovered nucleotide- binding oligomerization domain-like receptors (NLRs), have been recently proposed as key partners in the progression of several CVDs (e.g., atherosclerosis and heart failure). The present review discusses the key findings related to the involvement of TLRs and NLRs in the progression of several vascular and cardiac diseases, with a focus on whether some NLR subtypes (nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain-containing receptor 3 and nucleotide-binding oligomerization domain-containing protein 1) can be candidates for the development of new therapeutic strategies for several CVDs.
|Citation||Jaén, R.I., Val-Blasco, A., Prieto, P., Gil-Fernández, M., Smani Hajami, T. y López-Sendón, J.L. (2020). Innate Immune Receptors, Key Actors in Cardiovascular Diseases. JACC : Basic to translational Science, 5 (7), 735-749. https://doi.org/10.1016/j.jacbts.2020.03.015.|